Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Connecticut Medicine
|
January 1, 1996
"A violence prevention program targeting adolescents"
V K Sikand
Clinical and Diagnostic Laboratory Immunology
|
September 18, 1999
Diagnosis of Lyme borreliosis by a whole-blood gamma interferon assay for cell-mediated immune responses
V K Sikand, J S Rothel, R M Martin
Infection and Immunity
|
November 14, 2001
Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease
A Vaz, L Glickstein, J A Field, et al.
Clinical Therapeutics
|
August 30, 2000
Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months
R T Schoen, V K Sikand, M C Caldwell, et al.
Pediatrics
|
July 4, 2001
Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial
V K Sikand, N Halsey, P J Krause, et al.
The Journal of Infectious Diseases
|
March 9, 1999
Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice
R T Trevejo, P J Krause, V K Sikand, et al.
The New England Journal of Medicine
|
November 18, 2000
Atovaquone and azithromycin for the treatment of babesiosis
P J Krause, T Lepore, V K Sikand, et al.
The New England Journal of Medicine
|
July 17, 1998
Persistent parasitemia after acute babesiosis
P J Krause, A Spielman, S R Telford, et al.
The New England Journal of Medicine
|
July 23, 1998
Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group
A C Steere, V K Sikand, F Meurice, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Connecticut Medicine
|
January 1, 1996
"A violence prevention program targeting adolescents"
V K Sikand
Clinical and Diagnostic Laboratory Immunology
|
September 18, 1999
Diagnosis of Lyme borreliosis by a whole-blood gamma interferon assay for cell-mediated immune responses
V K Sikand, J S Rothel, R M Martin
Infection and Immunity
|
November 14, 2001
Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease
A Vaz, L Glickstein, J A Field, et al.
Clinical Therapeutics
|
August 30, 2000
Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months
R T Schoen, V K Sikand, M C Caldwell, et al.
Pediatrics
|
July 4, 2001
Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial
V K Sikand, N Halsey, P J Krause, et al.
The Journal of Infectious Diseases
|
March 9, 1999
Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice
R T Trevejo, P J Krause, V K Sikand, et al.
The New England Journal of Medicine
|
November 18, 2000
Atovaquone and azithromycin for the treatment of babesiosis
P J Krause, T Lepore, V K Sikand, et al.
The New England Journal of Medicine
|
July 17, 1998
Persistent parasitemia after acute babesiosis
P J Krause, A Spielman, S R Telford, et al.
The New England Journal of Medicine
|
July 23, 1998
Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group
A C Steere, V K Sikand, F Meurice, et al.
Page
of 1